| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) income | -1,034 | 5,772 | 13,963 | 31,951 |
| Depreciation and amortization expense | 45,395 | 53,774 | 46,195 | 92,137 |
| Equity in income of joint ventures | 3,231 | 3,838 | 5,897 | 7,101 |
| Changes in fair value of contingent consideration | NaN | -283 | 0 | 0 |
| Stock-based compensation expense | 7,274 | 7,689 | 7,201 | 14,282 |
| Elimination of unrealized loss on sales to joint ventures | -107 | -231 | 0 | 0 |
| Deferred taxes | -1,784 | -2,124 | -1,162 | -16,049 |
| Unrealized foreign exchange loss (gain) | -120 | 839 | 1,180 | 6,047 |
| Accounts receivable, net | 16,652 | -16,064 | -10,456 | -15,118 |
| Inventories | 177 | -3,821 | 3,656 | 9,020 |
| Other assets | 6,304 | 1,674 | 4,662 | 11,557 |
| Accounts payable and accrued liabilities | 11,468 | -30,283 | -17,510 | -17,289 |
| Other liabilities | -2,547 | 3,382 | 13,022 | 12,931 |
| Income taxes, net | -8,628 | 1,034 | 4,592 | -6,599 |
| Dividends received from joint ventures | 4,662 | 6,241 | 4,171 | 498 |
| Other | -3,385 | -1,896 | -2,354 | -3,333 |
| Net cash provided by operating activities | 25,284 | 57,071 | 63,179 | 89,922 |
| Payment for acquired businesses, net of cash acquired | NaN | 0 | 0 | 0 |
| Proceeds from settlement of contingent consideration | NaN | 0 | -5,000 | 5,000 |
| Proceeds from disposal of assets | NaN | 0 | 5,000 | NaN |
| Proceeds from sale / maturity of investments | NaN | 0 | NaN | NaN |
| Capital expenditures | 25,764 | 33,875 | 24,196 | 54,316 |
| Net cash used in investing activities | -25,764 | -33,875 | -24,196 | -49,316 |
| Cash pledged for collateral deposits, net | 0 | 105 | -137 | -415 |
| Payment of contingent consideration | NaN | 0 | NaN | NaN |
| Proceeds from long-term borrowings | NaN | 0 | 0 | 0 |
| Repayments of long-term borrowings | NaN | 20,000 | 22,000 | 0 |
| Repurchase of common stock | 19,998 | 0 | 25,055 | 15,033 |
| Payment of withholding taxes on stock-based compensation plans | 4,880 | 193 | -1,060 | 2,588 |
| Repayment of financed insurance premium | 0 | 4,264 | 1,497 | 4,955 |
| Repayments of finance leases | 518 | 317 | 546 | 887 |
| Net cash used in financing activities | -25,396 | -24,669 | -48,175 | -23,878 |
| Effect of exchange rate changes on cash and cash equivalents | -824 | 326 | 326 | 6,095 |
| Net decrease to cash and cash equivalents and restricted cash | -26,700 | -1,147 | -8,866 | 22,823 |
| Cash and cash equivalents at beginning of period | NaN | NaN | 184,663 | NaN |
| Cash and cash equivalents and restricted cash at beginning of period | 198,620 | NaN | NaN | NaN |
| Cash and cash equivalents at end of period | NaN | NaN | 198,620 | NaN |
| Cash and cash equivalents and restricted cash at end of period | 170,773 | NaN | NaN | NaN |
EXPRO GROUP HOLDINGS N.V. (XPRO)
EXPRO GROUP HOLDINGS N.V. (XPRO)